Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow

Core Viewpoint - Ekso Bionics Holdings, Inc. is set to release its financial and business results for Q2 2025 on July 28, 2025, with a conference call scheduled to discuss these results and recent developments [1]. Company Overview - Ekso Bionics is a leading developer of exoskeleton solutions aimed at enhancing human strength, endurance, and mobility for both medical and industrial applications [3]. - The company focuses on improving health and quality of life through advanced robotics that enhance, amplify, and restore human function [3]. - Ekso Bionics is unique in offering technologies that assist individuals with paralysis to stand and walk, as well as enhancing capabilities in various job sites globally [3]. - The company is headquartered in the San Francisco Bay Area and is publicly traded on the Nasdaq Capital Market under the symbol "EKSO" [3].